Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory

被引：0
作者：
Hristova, Mariyana [1 ]
机构：
[1] Med Ctr Varna, Div Endocrinol, Varna, Bulgaria
来源：
MEDICAL HYPOTHESES | 2017年 / 102卷
关键词：
TYPE-2; DIABETES-MELLITUS; METABOLIC SYNDROME; SGLT2; INHIBITORS; BLOOD-PRESSURE; KIDNEY-DISEASE; HYPOTHESIS; OUTCOMES; DAPAGLIFLOZIN; REABSORPTION; METAANALYSIS;
D O I：
10.1016/j.mehy.2017.02.021
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：61 / 64
页数：4
相关论文
共 50 条
  • [41] The Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Atrial Electromechanical Conduction Time
    Celik, Enes
    Kerkutluoglu, Murat
    Sahin, Murat
    Aksu, Ekrem
    Balcioglu, Akif Serhat
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2024, 52 (04): : 237 - 243
  • [42] Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
    Fatima, Aroob
    Rasool, Sohaib
    Devi, Sapna
    Talha, Muhammad
    Waqar, Fahad
    Nasir, Muhammad
    Khan, Mohammad R.
    Jaffari, Syed M. Ibne Ali
    Haider, Anum
    Shah, Syeda U.
    Sapna, Fnu
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    Mohamad, Tamam
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [43] Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure
    Docherty, Kieran F.
    Petrie, Mark C.
    [J]. HEART, 2022, 108 (04) : 312 - 320
  • [44] Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias
    Manolis, Antonis A.
    Manolis, Theodora A.
    Melita, Helen
    Manolis, Antonis S.
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (07) : 418 - 428
  • [45] Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
    Kalra, Sanjay
    Singh, Vikram
    Nagrale, Dinesh
    [J]. ADVANCES IN THERAPY, 2016, 33 (09) : 1502 - 1518
  • [46] Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies
    Alshnbari, Afnan S.
    Millar, Sophie A.
    O'Sullivan, Saoirse E.
    Idris, Iskandar
    [J]. DIABETES THERAPY, 2020, 11 (09) : 1947 - 1963
  • [47] Cardiovascular outcomes of sodium-glucose cotransporter 2 inhibitors: A comprehensive review of clinical and preclinical studies
    Ghosh, Raktim Kumar
    Bandyopadhyay, Dhrubajyoti
    Hajra, Adrija
    Biswas, Monodeep
    Gupta, Anjan
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 29 - 36
  • [48] Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives
    Mondal, Sunetra
    Pramanik, Subhodip
    Khare, Vibhu Ranjan
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (05): : 240 - 259
  • [49] The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)-A Narrative Review
    Iordan, Liana
    Gaita, Laura
    Timar, Romulus
    Avram, Vlad
    Sturza, Adrian
    Timar, Bogdan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [50] Different Sodium-Glucose Cotransporter-2 Inhibitors: Can They Prevent Death
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    [J]. ENDOCRINE PRACTICE, 2022, 28 (08) : 795 - 801
12345